Bimatoprost
بیماتوپروست
👁️ Sensory OrgansProstaglandin analogue (ophthalmic)
Market / country: 🇺🇸 USA
Lumigan (US)
🧮 Dose calculator
Open-angle glaucoma / ocular hypertension · Regimen source: FDA Lumigan 0.01% · 2
- • More than once daily reduces the effect. Separate other drops by 5 min. FDA Lumigan 0.01% · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to bimatoprost. FDA Lumigan 0.01% · 4
Warnings
- • Increased iris (permanent), eyelid pigmentation and eyelash changes; intraocular inflammation; macular oedema. FDA Lumigan 0.01% · 5
Formulations
- 0.01% (0.1 mg/mL) eye drops — eye drops 🇺🇸 USA FDA Lumigan 0.01% · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Lumigan 0.01% · 8.1
“Risk Summary There are no adequate and well-controlled studies of LUMIGAN ® (bimatoprost ophthalmic solution) 0.01% administration in pregnant women.”
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Lumigan 0.01% · 8.4
“Use in pediatric patients below the age of 16 years is not recommended because of potential safety concerns related to increased pigmentation following long-term chronic use.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Lumigan 0.01% · 8.5
“No overall clinical differences in safety or effectiveness have been observed between elderly and other adult patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA022184
- DailyMed (FDA label)FDA Lumigan 0.01%
- MedlinePlus (NIH)Bimatoprost OphthalmicBimatoprost Topical
- WHO ATC/DDDS01EE03
- Darooyab (Iran)Bimatoprost
🇮🇷 Registered in Iran Darooyab · G-3176/Bimatoprost
Dosage forms with Iranian generic codes, per Darooyab.
- 17537 · BIMATOPROST 0.03% OPH GEL · ژل بیماتوپروست ۰٫۰۳ درصد
- 08581 · BIMATOPROST 0.3MG/ML 3ML OPH DROP · قطره چشمی بیماتوپروست ۰٫۳ میلیگرم / میلیلیتر ۳ میلیلیتر
- 52082 · BIMATOPROST SOLUTION, DROPS OPHTHALMIC 0.03 % 3 mL · قطره چشمی بیماتوپروست ۰٫۰۳ درصد ۳ میلیلیتر
- 52781 · BIMATOPROST SOLUTION, DROPS OPHTHALMIC 0.01 % 0.5 mL · قطره چشمی بیماتوپروست ۰٫۰۱ درصد ۰٫۵ میلیلیتر
- 52782 · BIMATOPROST SOLUTION, DROPS OPHTHALMIC 0.03 % 0.5 mL · قطره چشمی بیماتوپروست ۰٫۰۳ درصد ۰٫۵ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Lumigan 0.01% · 3FDA Lumigan 0.01% · 2FDA Lumigan 0.01% · 4FDA Lumigan 0.01% · 5FDA Lumigan 0.01% · SPL approval / marketing categoryFDA Lumigan 0.01% · 8.1FDA Lumigan 0.01% · 8.4FDA Lumigan 0.01% · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3176/Bimatoprost
- Clinical review⚠ Unverified